Direkt zum Inhalt
Merck

Methimazole embryopathy: delineation of the phenotype.

American journal of medical genetics (1999-03-17)
M Clementi, E Di Gianantonio, E Pelo, I Mammi, R T Basile, R Tenconi
ZUSAMMENFASSUNG

We report on a further case of congenital anomalies in a child exposed to methimazole during the first trimester of pregnancy (from first to seventh gestational week), and define a specific malformation pattern related to prenatal methimazole exposure and consisting of choanal and esophageal atresia, scalp defects, minor facial anomalies and psychomotor delay.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
2-Mercapto-1-methylimidazol, ≥99%
USP
Methimazol, United States Pharmacopeia (USP) Reference Standard
Supelco
Methimazol, analytical standard
Thiamazol, European Pharmacopoeia (EP) Reference Standard
Supelco
Methimazol, VETRANAL®, analytical standard